Acadia Pharmaceuticals buy Cantor Fitzgerald
Start price
28.02.24
/
50%
€21.80
Target price
28.02.25
€38.75
Performance (%)
-28.37%
Price
26.04.24
€15.62
Summary
This prediction is currently active. The prediction for Acadia Pharmaceuticals disappoints with a performance of -28.37%. This prediction currently runs until 28.02.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Acadia Pharmaceuticals | 0.807% | 0.807% |
iShares Core DAX® | -0.992% | -3.231% |
iShares Nasdaq 100 | -0.225% | -3.339% |
iShares Nikkei 225® | -0.736% | -7.859% |
iShares S&P 500 | -0.509% | -2.979% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $42.00 price target on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€15.79
30.04.24
30.04.24
€34.52
30.04.25
30.04.25
0.00%
26.04.24
26.04.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€16.50
10.04.24
10.04.24
€34.38
10.04.25
10.04.25
-5.36%
26.04.24
26.04.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€23.60
02.02.24
02.02.24
€38.87
02.02.25
02.02.25
-33.83%
26.04.24
26.04.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€25.60
14.12.23
14.12.23
€38.21
14.12.24
14.12.24
-39.00%
26.04.24
26.04.24